CVE-2018-19855
UiPath Orchestrator before 2018.3.4 allows CSV Injection, related to the Audit export, Robot log...
UiPath Orchestrator before 2018.3.4 allows CSV Injection, related to the Audit export, Robot log export, and Transaction log export features.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- None
- Integrity
- High
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
5.5
UiPath Orchestrator before 2018.3.4 allows CSV Injection, related to the Audit export, Robot log export, and Transaction log export features.
- Record
CVE-2018-19855- CVSS 3.0
- 5.5 Medium
CVSS:3.0/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N - CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-1236
- Updated
- 2026-11-02
CVE List No score
UiPath Orchestrator before 2018.3.4 allows CSV Injection, related to the Audit export, Robot log export, and Transaction log export features.
- Record
CVE-2018-19855- Updated
- 2026-11-02
EUVDEUVD-2018-11530 No score
UiPath Orchestrator before 2018.3.4 allows CSV Injection, related to the Audit export, Robot log export, and Transaction log export features.
- Record
EUVD-2018-11530- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-v7q2-p828-26rj No score
UiPath Orchestrator before 2018.3.4 allows CSV Injection, related to the Audit export, Robot log...
UiPath Orchestrator before 2018.3.4 allows CSV Injection, related to the Audit export, Robot log export, and Transaction log export features.
- Record
GHSA-v7q2-p828-26rj- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2018-19855 is a medium vulnerability (CVSS 5.5) in Uipath Orchestrator, published August 8, 2019. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.09%, the 65th percentile. No source names a fixed version.